Literature DB >> 22088258

Impact of residual ethmoid cells on postoperative course after endoscopic sinus surgery for chronic rhinosinusitis.

Tetsushi Okushi1, Eri Mori, Tsuguhisa Nakayama, Daiya Asaka, Yoshinori Matsuwaki, Kazunori Ota, Shintaro Chiba, Hiroshi Moriyama, Nobuyoshi Otori.   

Abstract

OBJECTIVE: Endoscopic sinus surgery (ESS) is a worldwide standard surgical procedure for chronic rhinosinusitis (CRS). Residual ethmoid cells (RECs), which result from failure to completely remove them, have been thought to be a cause of recurrence of CRS. Our objective was to investigate the relationship between the REC score and post ESS recurrence of CRS.
METHODS: From January 2002 through December 2003, a total of 138 consecutive CRS patients (86 men and 52 women; mean age: 44 years) underwent ESS at the Department of Otorhinolaryngology, Ota General Hospital. CT was performed at 6 or more months post ESS for all patients. The left and right ethmoid sinuses were each divided into superior-anterior, inferior-anterior and posterior parts. The extent of RECs in each part was assessed using a 3-grade scoring system. The outcome of CRS was classified into a satisfactory outcome group and a poor outcome group based on the improvement rate determined from the pre ESS and post ESS CT image findings. The two groups were then compared for the age, gender, presence/absence of nasal polyps, presence/absence of allergic rhinitis, presence/absence of asthma, the peripheral eosinophil count (%) and the total REC score. In addition, the individual correlations between the above variables and the poor outcome group were analyzed by logistic regression analysis.
RESULTS: The total REC score was 0 in only 35 (25.4%) of the total patients. The most common total REC scores were 1-6 in 85 (61.6%) patients. The superior-anterior part had the largest number of patients with an REC score of 1 or more. The satisfactory outcome group comprised 97 patients (70.3%), while the poor outcome group comprised 41 patients (29.7%). Comparison of these two groups found that the peripheral eosinophil count, the prevalence rate of asthma and the total REC score were each significantly higher in the poor outcome group than in the satisfactory outcome group. Logistic regression analysis identified a peripheral eosinophil count of ≥9.5%, the presence of asthma and a total REC score of ≥4 as factors that correlated significantly with a poor outcome.
CONCLUSION: The findings of this study indicate that RECs are involved in the recurrence of CRS following ESS. It can be thought that how to achieve full opening of the superior-anterior part of the ethmoid sinus, which includes the frontal recess, will be an issue in the future.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22088258     DOI: 10.1016/j.anl.2011.09.001

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  5 in total

1.  Impact of residual frontal recess cells on frontal sinusitis after endoscopic sinus surgery.

Authors:  Tsuguhisa Nakayama; Daiya Asaka; Akihito Kuboki; Tetsushi Okushi; Hiromi Kojima
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-18       Impact factor: 2.503

2.  Patterns of Pneumatization of the Posterior Nasal Roof.

Authors:  Alexandru Nicolae Mureșan; Mugurel Constantin Rusu; Petrinel Mugurel Rădoi; Corneliu Toader
Journal:  Tomography       Date:  2022-02-02

3.  Assessment of the necessity of frontal sinostomy in cases of frontal sinusitis associated with fungus ball of the maxillary sinus.

Authors:  Dong Wang; Yichen Li; Hongting Hua; Yi Zhao; Chao-Bing Gao; Ping Fang
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-15       Impact factor: 2.503

4.  Anatomy of the posterior and middle ethmoidal arteries via computed tomography.

Authors:  Hiroki Yamamoto; Kazuhiro Nomura; Hiroshi Hidaka; Yukio Katori; Naohiro Yoshida
Journal:  SAGE Open Med       Date:  2018-04-27

5.  Lateral frontoethmoidal cell obstructing frontal sinus drainage pathway - report of six cases.

Authors:  Tomasz Gotlib; Magdalena Kuźmińska; Paulina Kołodziejczyk; Kazimierz Niemczyk
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2018-05-22       Impact factor: 1.195

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.